The genus Chryseobacterium, defined in 1994 by Vandamme et al., comprises six species, including Chryseobacterium meningosepticum (previously Flavobacterium meningosepticum) and Chryseobacterium indologenes (previously Flavobacterium indologenes), which are the most common clinical species of this genus (29). C. meningosepticum isolates are associated with meningitis in newborns or in immunocompromised patients (4). C. indologenes is responsible mostly for nosocomial infections linked to the use of intravascular devices (10, 28). In 1997, Hsueh et al. reported 36 cases of infections caused by C. indologenes over a 3-year period at the National Taiwan University Hospital (11). These infections were intra-abdominal infections, biliary tract infections, or wound sepsis (11). C. indologenes is also implicated in pneumonia (9). C. indologenes is resistant to nearly all penicillins, except piperacillin, to restricted-spectrum cephalosporins, to aztreonam, and to carbapenems (1). Among -lactams, only extended-spectrum cephalosporins show in vitro activity against C. indologenes (8). Minocycline and ciprofloxacin seem to be the most effective antibiotics and have been successfully used to treat C. indologenes infections (10).Recently, two Ambler class B -lactamases have been characterized for C. meningosepticum, which is also resistant to all -lactams, including carbapenems (2, 26). The unrelated BlaB and GOB-1 exhibit a broad-spectrum profile and are chromosome encoded. These carbapenem-hydrolyzing -lactamases (CHLs) have molecular and biochemical heterogeneity among C. meningosepticum isolates. We have characterized a -lactamase, IND-1, from C. indologenes strain 001 (1). Since plasmid-mediated CHLs have been increasingly reported for gram-negative species worldwide (5,12,18,23,24,25), it was of interest to identify naturally occurring CHLs of gramnegative species and to search for their degree of identity with the plasmid-mediated CHLs. Thus, we performed an extended genetic and biochemical study of -lactamase-mediated resistance to carbapenems in C. indologenes.
MATERIALS AND METHODSBacterial strains. The bacterial strains used in this work are listed in Table 1. C. indologenes 002, 007, 008, and 009 were isolated from bronchoalveolar brush border, blood culture, rectal swab, and biliary liquid drainage, respectively, at the Hôpital de Bicêtre (Le Kremlin-Bicêtre, France) from 1997 to 1999. C. indologenes 003 and 004 were isolated from blood cultures at the Hôpital Robert Debré (Paris, France). C. indologenes 005 was from the Assistance Publique-Hôpitaux de Marseille (Marseille, France). C. indologenes 006 was isolated at the Hôpital de la Pitié Salpêtrière (Paris, France), and the C. indologenes reference strain CIP101026 was from the Pasteur Institute (Paris, France) strain collection. Each C. indologenes isolate was identified according to standard biochemical techniques (19,29,31), and their identification was checked at the Center for Bacterial Identification at the Pasteur Institute. These C. indolog...